Astellas Pharma is advancing AI-powered drug discovery research and seeking to improve efficiency by introducing Microsoft's platform and collaborating with Microsoft. In response to an interview by Kyodo News, Mori Kenichi (森健一) explained the current situation.
Astellas Pharma is promoting AI-powered drug discovery research and pursuing initiatives to streamline the drug discovery process. The article also mentions that the company has introduced Microsoft's platform.
Mori Kenichi (森健一), who leads the drug discovery effort, responded to an interview by Kyodo News and explained the current status and future direction of AI-powered research. The interview is reported to have continued through the 20th. The article states that the company is considering candidates for new drugs.